A Study of Targeted Post-Surgery Radiation Therapy for Lung Cancer with Remaining Lymph Node Cancer After Treatment

Full Title

Involved-Station, Intensity-Modulated Post-Operative Radiation Therapy (I²-PORT) for Resected Non-Small Cell Lung Cancer with Residual Mediastinal Adenopathy After Neoadjuvant Therapy (ypN2) (A082402) (CIRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Daphna Gelblum’s office at 914-367-7273.